Condition causing lifelong high cholesterol linked to pregnancy complication
Women with an inherited condition that causes lifelong high cholesterol may face a modestly higher risk of developing preeclampsia during pregnancy, according to a new study published in the European Journal of Preventive Cardiology. The research focuses on familial hypercholesterolemia, a genetic disorder that leaves cholesterol levels elevated from birth and, if untreated, raises the risk of early heart disease. The findings suggest that pregnancy may offer an early window into cardiovascular vulnerability in these women, linking a condition long managed in cardiology clinics to outcomes traditionally watched by obstetricians. The study adds to a growing body of evidence that heart and pregnancy health are deeply intertwined.
Familial hypercholesterolemia is one of the most common inherited metabolic disorders, affecting roughly one in every 250 to 300 people worldwide, though it remains widely underdiagnosed. Because the condition is present from birth, affected individuals are exposed to high levels of LDL, or bad cholesterol, for decades, accelerating the buildup of plaque in arteries. Many people learn they have it only after a heart attack or when a family member is diagnosed. In India, awareness remains low even among physicians, and screening is not routine, meaning a large share of cases go unrecognized until complications arise. For women, the condition carries particular implications during pregnancy, when the body undergoes significant metabolic and vascular changes.
Preeclampsia is a serious pregnancy complication marked by high blood pressure and signs of damage to organs such as the kidneys or liver, typically appearing after 20 weeks of gestation. It affects a minority of pregnancies but is a leading cause of maternal illness and death globally, and it increases the long-term risk of heart disease for the mother. The new study examined whether women with familial hypercholesterolemia were more likely to develop the condition than women without it, and the researchers reported an association suggesting a slightly elevated risk. The authors caution that the findings are observational and do not establish that high cholesterol directly causes preeclampsia. Still, the link is biologically plausible, since both conditions involve impaired function of the blood vessels.
Clinicians and researchers say the study reinforces the case for earlier diagnosis of familial hypercholesterolemia, particularly in women of childbearing age. Women who know they carry the condition can be monitored more closely during pregnancy and can receive appropriate cholesterol-lowering treatment before and after delivery, when it is considered safe. The findings also suggest that a history of preeclampsia might prompt doctors to look for underlying cholesterol disorders in their patients. Patient advocacy groups have long argued that familial hypercholesterolemia is neglected in women because it is often framed as a male problem. The new research may help shift that perception by tying the condition to a distinctly female health experience.
The study fits into a broader recognition that pregnancy complications can serve as early indicators of future cardiovascular risk. Conditions such as gestational diabetes, gestational hypertension and preeclampsia are increasingly viewed not as isolated events but as stress tests that reveal underlying susceptibility. At the same time, cardiology and obstetrics have historically operated in separate silos, and experts have called for greater collaboration between the two fields. The rising burden of heart disease among Indian women, combined with late diagnosis of inherited cholesterol disorders, makes this intersection particularly relevant. Public health experts note that simple lipid screening and family history taking could identify many at-risk women before they become pregnant.
The history of familial hypercholesterolemia research offers useful perspective. The condition was first described clinically in the 1930s, and its genetic basis was established decades later, work that eventually earned a Nobel Prize. For much of that history, studies focused overwhelmingly on men, since heart attacks in younger men were more visible and better documented. Even today, women with the disorder are diagnosed later and treated less aggressively than men in many countries. Recognizing pregnancy-related complications as a warning sign is a relatively recent shift, and the new study extends that thinking to an inherited cholesterol disorder. Similar links have been documented between familial hypercholesterolemia and other pregnancy outcomes, though evidence remains limited.
Researchers say larger studies are needed to confirm the association and to understand whether treating high cholesterol before pregnancy reduces the risk of preeclampsia. Future work may also examine whether women with preeclampsia should be screened for familial hypercholesterolemia as a matter of course. In the meantime, experts recommend that women with a known family history of very high cholesterol or early heart disease discuss screening with their doctors, especially before planning a pregnancy. Guidelines on cholesterol management in pregnancy are expected to evolve as evidence accumulates. For now, the study serves as a reminder that the heart risks facing women often begin long before the symptoms that bring them to a clinic.
